EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits

Lorenzo-Lupo Dei iD, Jennie Han iD, Silvio Romano iD, Luigi Sciarra iD, Angeliki Asimaki iD, Michael Papadakis iD, Sanjay Sharma iD, Gherardo Finocchiaro iD

Journal of the American Heart Association · 17.06.2025 · 14 (12)

DOI: 10.1161/jaha.124.039125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 17.06.2025. Verfasst von Lorenzo-Lupo Dei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences University of L'Aquila Italy. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Death, Sudden, Cardiac, Exercise Therapy, Exercise. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac condition, often caused by mutations in genes encoding desmosomal proteins. The pathologic hallmark of the disease is a fibrofatty replacement of the myocardium, which constitutes the substrate for potentially fatal ventricular arrhythmias. ACM is one of the most common etiology of sudden cardiac death in athletes and young individuals. Although it is well established that regular exercise confers multiple health benefits and better survival in the general population, intense exercise may accelerate the phenotypic expression and the propensity to ventricular arrhythmias in patients with ACM. This review discusses current evidence regarding the safety and the effects of exercise in ACM. We scrutinize research findings based on animal and human models that raise concerns on the possible detrimental role of intense exercise in this condition. Finally, we examine the current knowledge on exercise prescription focusing on the optimal amount of exercise that should be recommended to patients with ACM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaDeath, Sudden, CardiacExercise TherapyExerciseHumansAnimalsRisk AssessmentRisk FactorsPhenotype

Stichwörter der Autor:innen

arrhythmogenic cardiomyopathycardiomyopathiesdeath, sudden, cardiacexercise

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Sciences University of L'Aquila Italy.
  • Cardiovascular Sciences Research Centre, St George's University of London UK.
  • St Mary's Hospital Imperial College Healthcare NHS Trust London UK.

ORCID-Profile: Lorenzo-Lupo Dei, Jennie Han, Silvio Romano, Luigi Sciarra, Angeliki Asimaki, Michael Papadakis, Sanjay Sharma, Gherardo Finocchiaro

Zitieren

APA

Dei, L. L., Han, J., Romano, S., Sciarra, L., Asimaki, A., Papadakis, M., Sharma, S., & Finocchiaro, G. (2025). Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits. Journal of the American Heart Association, 14(12). https://doi.org/10.1161/jaha.124.039125

Vancouver

Dei LL, Han J, Romano S, Sciarra L, Asimaki A, Papadakis M, et al. Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits. Journal of the American Heart Association. 2025;14(12). doi:10.1161/jaha.124.039125

BibTeX
@article{Dei2025,
  author = {Dei, Lorenzo-Lupo and Han, Jennie and Romano, Silvio and Sciarra, Luigi and Asimaki, Angeliki and Papadakis, Michael and Sharma, Sanjay and Finocchiaro, Gherardo},
  title = {Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {12},
  doi = {10.1161/jaha.124.039125}
}
Kostenlos starten →